Sci Rep 6:31899 Chin Y-T, Wang L-M, Hsieh M-T, Shih Y-J, Nana AW, Changou CA, Yang Y-CS, Chiu H-C, Fu E et al (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells
It is not medical advice and not a recommendation to use any compound
United States (FDA and DSHEA) Not FDA-approved for weight loss or fat-burning claims AOD9604 was previously investigated as a potential obesity treatment, but the FDA has not approved it as a prescription medication (FDA PCAC briefing)
Factors that may influence provider recommendations include: Personal wellness goals Body composition and metabolic rate Nutrient levels or oxidative stress status Whether injections are administered intravenously or intramuscularly Findings from a licensed healthcare providers evaluation, such as labs or symptom history Licensed healthcare providers may start with lower doses, such as 600 mg weekly, and adjust based on individual response and tolerance
Mud greater than 10-micron is deposited in bags for easy disposal